DRUG-RECEPTOR DISSOCIATION TIME, NEW TOOL FOR DRUG RESEARCH - RECEPTOR-BINDING AFFINITY AND DRUG-RECEPTOR DISSOCIATION PROFILES OF SEROTONIN-S2, DOPAMINE-D2, HISTAMINE-H-1 ANTAGONISTS, AND OPIATES

被引：74

作者：

LEYSEN, JE

GOMMEREN, W

机构：

来源：

DRUG DEVELOPMENT RESEARCH | 1986年 / 8卷 / 1-4期

关键词：

D O I：

10.1002/ddr.430080115

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：119 / 131

页数：13

共 24 条

[1]

AWOUTERS F, 1980, ACS S SERIES, V118, P179

[2]

BLACKSHEAR MA, 1982, J PHARMACOL EXP THER, V221, P303

[3] THE SEROTONIN-S2 RECEPTOR - A RECEPTOR-TRANSDUCER COUPLING MODEL TO EXPLAIN INSURMOUNTABLE ANTAGONIST EFFECTS [J].

DECOURCELLES, DC ;

LEYSEN, JE ;

ROEVENS, P ;

VANBELLE, H .

DRUG DEVELOPMENT RESEARCH, 1986, 8 (1-4) :173-178

[4]

Frostad A B, 1984, Acta Otolaryngol Suppl, V409, P1

[5] DIFFERENT EFFECTS OF SEROTONIN ANTAGONISTS ON H-3 MIANSERIN AND H-3 KETANSERIN RECOGNITION SITES [J].

GANDOLFI, O ;

BARBACCIA, ML ;

COSTA, E .

LIFE SCIENCES, 1985, 36 (08) :713-721

[6]

GANDOLFI O, 1984, J PHARMACOL EXP THER, V229, P782

[7]

JANSSEN PAJ, 1985, J CARDIOVASC PHARM, V7, pS2

[8]

JANSSEN PAJ, 1968, ARZNEI-FORSCHUNG, V18, P261

[9]

LADURON PM, 1982, MOL PHARMACOL, V21, P294

[10] DOMPERIDONE, A SPECIFIC INVITRO DOPAMINE ANTAGONIST, DEVOID OF INVIVO CENTRAL DOPAMINERGIC ACTIVITY [J].

LADURON, PM ;

LEYSEN, JE .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (14) :2161-2165

← 1 2 3 →